Raymond James lowered the firm’s price target on ICU Medical (ICUI) to $180 from $187 and keeps a Strong Buy rating on the shares. The Q2 beat gives the firm confidence that underlying business momentum is improving, and this trend should to continue with various new product launches and ongoing efforts to optimize the cost structure, the analyst tells investors in a research note.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ICUI: